ARCHEAN CHEMICAL INDUSTRIES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 671.9 INR | +2.22% |
|
+8.01% | +3.42% |
Valuation
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| Capitalization 1 | 80,040 | 82,553 | 82,910 | - | - |
| Enterprise Value (EV) 1 | 80,040 | 82,553 | 80,300 | 75,698 | 82,910 |
| P/E ratio | 18.8 x | 25.9 x | 18.6 x | 13.1 x | 10.6 x |
| Yield | - | - | 0.89% | 1.65% | 1.04% |
| Capitalization / Revenue | 5.55 x | 6.21 x | 4.75 x | 3.53 x | 3.02 x |
| EV / Revenue | 5.55 x | 6.21 x | 4.6 x | 3.22 x | 3.02 x |
| EV / EBITDA | 12.6 x | 17.8 x | 12.5 x | 8.46 x | 7.6 x |
| EV / FCF | 20.2 x | 33.2 x | 24.1 x | 15.3 x | 13.1 x |
| FCF Yield | 4.95% | 3.01% | 4.15% | 6.53% | 7.65% |
| Price to Book | 5.59 x | 4.85 x | 3.93 x | 3.1 x | 2.35 x |
| Nbr of stocks (in thousands) | 123,053 | 123,397 | 123,397 | - | - |
| Reference price 2 | 650.4 | 669.0 | 671.9 | 671.9 | 671.9 |
| Announcement Date | 23-05-26 | 24-05-14 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Net sales 1 | 11,304 | 14,411 | 13,301 | 17,468 | 23,483 | 27,452 |
| EBITDA 1 | - | 6,340 | 4,627 | 6,405 | 8,951 | 10,905 |
| EBIT 1 | - | 5,654 | 3,923 | 5,635 | 8,104 | 9,912 |
| Operating Margin | - | 39.23% | 29.5% | 32.26% | 34.51% | 36.11% |
| Earnings before Tax (EBT) 1 | - | 5,117 | 4,272 | 5,918 | 8,398 | 10,383 |
| Net income 1 | - | 3,826 | 3,190 | 4,444 | 6,306 | 7,830 |
| Net margin | - | 26.55% | 23.98% | 25.44% | 26.85% | 28.52% |
| EPS 2 | 18.22 | 34.59 | 25.87 | 36.05 | 51.20 | 63.55 |
| Free Cash Flow 1 | - | 3,962 | 2,484 | 3,332 | 4,946 | 6,344 |
| FCF margin | - | 27.5% | 18.67% | 19.08% | 21.06% | 23.11% |
| FCF Conversion (EBITDA) | - | 62.5% | 53.68% | 52.03% | 55.25% | 58.17% |
| FCF Conversion (Net income) | - | 103.57% | 77.86% | 74.99% | 78.44% | 81.02% |
| Dividend per Share 2 | - | - | - | 6.000 | 11.10 | 7.000 |
| Announcement Date | 22-05-31 | 23-05-26 | 24-05-14 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 3,824 | 3,431 | 2,905 | 4,126 | 2,839 |
| EBITDA 1 | - | 1,944 | 1,346 | 954.6 | 1,454 | 871.2 |
| EBIT 1 | - | - | 1,171 | 779.5 | 1,278 | 694.6 |
| Operating Margin | - | - | 34.14% | 26.84% | 30.97% | 24.47% |
| Earnings before Tax (EBT) 1 | - | - | 1,250 | 872.9 | 1,351 | 797.2 |
| Net income 1 | 980.6 | - | 938.6 | 660 | 1,015 | 575.9 |
| Net margin | - | - | 27.36% | 22.72% | 24.61% | 20.29% |
| EPS 2 | 8.710 | - | 7.600 | 5.340 | 8.230 | 4.640 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 23-02-10 | 23-05-26 | 23-08-11 | 23-10-31 | 24-02-03 | 24-05-14 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | - | 2,610 | 7,212 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 3,962 | 2,484 | 3,332 | 4,946 | 6,344 |
| ROE (net income / shareholders' equity) | - | 45.2% | 20.4% | 24% | 26.4% | 24.9% |
| ROA (Net income/ Total Assets) | - | - | 16.7% | 20.7% | - | - |
| Assets 1 | - | - | 19,057 | 21,466 | - | - |
| Book Value Per Share 2 | - | 116.0 | 138.0 | 171.0 | 217.0 | 286.0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 999 | 1,310 | 1,460 | 1,000 | 1,200 |
| Capex / Sales | - | 6.93% | 9.85% | 8.36% | 4.26% | 4.37% |
| Announcement Date | 22-05-31 | 23-05-26 | 24-05-14 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
671.9
INR
Average target price
757.2
INR
Spread / Average Target
+12.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.42% | 994M | |
| +22.66% | 69.48B | |
| -6.21% | 46.58B | |
| +22.70% | 44.61B | |
| +30.86% | 28.14B | |
| +7.64% | 19.39B | |
| +14.21% | 17.08B | |
| -10.45% | 15.2B | |
| -25.49% | 14.99B | |
| -30.99% | 11.87B |
- Stock Market
- Equities
- ACI Stock
- Financials Archean Chemical Industries Limited
